• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经腹腔单纯腹腔镜根治性肾输尿管切除术治疗上尿路尿路上皮癌的手术技术及肿瘤学结局

Surgical techniques and oncological outcomes of pure transperitoneal laparoscopic radical nephroureterectomy for upper urinary tract urothelial carcinoma.

作者信息

Yuan Changwei, Xu Chunru, Li Zhihua, Meng Chang, Du Yicong, Zhang Cuijian, Fang Dong, Li Xuesong, Zhou Liqun

机构信息

Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China.

出版信息

Transl Androl Urol. 2023 Jun 30;12(6):952-959. doi: 10.21037/tau-22-653. Epub 2023 May 31.

DOI:10.21037/tau-22-653
PMID:37426601
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10323451/
Abstract

BACKGROUND

Open radical nephroureterectomy (RNU) with bladder cuff excision is the standard treatment for upper urinary tract urothelial carcinoma (UTUC). Traditional laparoscopic radical nephroureterectomy (LSRNU) is not minimally invasive enough due to the complex surgical procedure. This study aims to discuss the clinical feasibility and oncological outcomes of pure transperitoneal LSRNU for UTUC.

METHODS

Between July 2010 and December 2020, 115 patients were admitted to the hospital with the diagnosis of UTUC treated with pure LSRNU by one surgeon. A special laparoscopic bulldog clamp was placed at the bladder cuff before cutting and suturing. The clinical and follow-up data were preoperatively collected and analyzed. Overall survival (OS) and cancer-specific survival (CSS) were estimated by the Kaplan-Meier method.

RESULTS

All surgeries were completed uneventfully in this cohort. The mean operative time was 145.69 minutes. The mean estimated blood loss was 56.61 mL. The mean removal time of the drain was 3.46 days. The mean time of having liquid diet was 1.32 days, and the ambulation time was 1.50 days. All surgeries were effectively completed, and no case required open conversion. According to the Clavien-Dindo classification system, postoperative complications occurred in two patients (II, III). The mean length of postoperative hospital stay was 5.78 days. The mean follow-up duration was 54.50 months. Recurrence in the bladder was 16.0% (15/94), compared with 4.6% (4/87) in the contralateral upper tract. The 5-year OS and CSS rates were 78.9% and 81.4%, respectively.

CONCLUSIONS

Pure transperitoneal LSRNU is a safe and effective minimally invasive technology for the treatment of UTUC.

摘要

背景

开放性根治性肾输尿管切除术(RNU)并膀胱袖状切除术是上尿路尿路上皮癌(UTUC)的标准治疗方法。传统的腹腔镜根治性肾输尿管切除术(LSRNU)由于手术操作复杂,微创程度不够。本研究旨在探讨单纯经腹腔LSRNU治疗UTUC的临床可行性和肿瘤学结局。

方法

2010年7月至2020年12月,115例诊断为UTUC的患者入院,由一名外科医生采用单纯LSRNU进行治疗。在切割和缝合前,在膀胱袖状部位放置一种特殊的腹腔镜牛头钳。术前收集并分析临床和随访数据。采用Kaplan-Meier法估计总生存期(OS)和癌症特异性生存期(CSS)。

结果

该队列中的所有手术均顺利完成。平均手术时间为145.69分钟。平均估计失血量为56.61毫升。引流管平均拔除时间为3.46天。平均流食时间为1.32天,下床活动时间为1.50天。所有手术均有效完成,无一例需要转为开放手术。根据Clavien-Dindo分类系统,两名患者发生术后并发症(Ⅱ级、Ⅲ级)。术后平均住院时间为5.78天。平均随访时间为54.50个月。膀胱复发率为16.0%(15/94),对侧上尿路复发率为4.6%(4/87)。5年OS率和CSS率分别为78.9%和81.4%。

结论

单纯经腹腔LSRNU是一种安全有效的微创技术,可用于治疗UTUC。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb6/10323451/7033a2215d07/tau-12-06-952-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb6/10323451/dbcc7da34706/tau-12-06-952-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb6/10323451/3dd9d65bfb4c/tau-12-06-952-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb6/10323451/7033a2215d07/tau-12-06-952-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb6/10323451/dbcc7da34706/tau-12-06-952-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb6/10323451/3dd9d65bfb4c/tau-12-06-952-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eb6/10323451/7033a2215d07/tau-12-06-952-f3.jpg

相似文献

1
Surgical techniques and oncological outcomes of pure transperitoneal laparoscopic radical nephroureterectomy for upper urinary tract urothelial carcinoma.经腹腔单纯腹腔镜根治性肾输尿管切除术治疗上尿路尿路上皮癌的手术技术及肿瘤学结局
Transl Androl Urol. 2023 Jun 30;12(6):952-959. doi: 10.21037/tau-22-653. Epub 2023 May 31.
2
Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review.腹腔镜肾输尿管切除术与开放根治性肾输尿管切除术治疗上尿路尿路上皮癌的肿瘤学结局:欧洲泌尿外科学会指南系统评价。
Eur Urol Focus. 2019 Mar;5(2):205-223. doi: 10.1016/j.euf.2017.10.003. Epub 2017 Nov 15.
3
Perioperative, renal function and oncological outcomes of robot-assisted radical nephroureterectomy for patients with upper tract urothelial carcinoma.机器人辅助根治性肾输尿管切除术治疗上尿路尿路上皮癌患者的围手术期、肾功能和肿瘤学结果。
World J Urol. 2023 Nov;41(11):3001-3007. doi: 10.1007/s00345-023-04590-x. Epub 2023 Sep 7.
4
A Modified and Practical Surgical Technique for Pure Transperitoneal Laparoscopic Radical Nephroureterectomy in a Single Position and Research Outcomes.一种改良实用的单体位纯经腹腹腔镜根治性肾输尿管切除术及研究结果
J Laparoendosc Adv Surg Tech A. 2023 Jul;33(7):691-697. doi: 10.1089/lap.2022.0527. Epub 2022 Dec 27.
5
Comparison of oncological outcomes for open and laparoscopic radical nephroureterectomy: results from the Canadian Upper Tract Collaboration.开放和腹腔镜根治性肾输尿管切除术的肿瘤学结果比较:来自加拿大上尿路协作组的结果。
BJU Int. 2013 Oct;112(6):791-7. doi: 10.1111/j.1464-410X.2012.11474.x. Epub 2012 Nov 13.
6
Factors Predicting Oncological Outcomes of Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma in Taiwan.台湾上尿路尿路上皮癌根治性肾输尿管切除术肿瘤学结局的预测因素
Front Oncol. 2022 Jan 13;11:766576. doi: 10.3389/fonc.2021.766576. eCollection 2021.
7
Robotic Radical Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma: A Trend Analysis of Utilization and a Comparative Study.机器人辅助根治性肾输尿管切除术联合膀胱袖状切除术治疗上尿路尿路上皮癌:应用趋势分析及对比研究
Cancers (Basel). 2022 May 19;14(10):2497. doi: 10.3390/cancers14102497.
8
Surgical outcome predictor analysis following hand-assisted or pure laparoscopic transperitoneal nephroureterectomy using the Taiwan upper urinary tract urothelial carcinoma database.使用台湾上尿路尿路上皮癌数据库对手助或单纯腹腔镜经腹肾输尿管切除术的手术结果预测因素分析。
Front Surg. 2022 Sep 1;9:934355. doi: 10.3389/fsurg.2022.934355. eCollection 2022.
9
Laparoscopic versus open nephroureterectomy to treat localized and/or locally advanced upper tract urothelial carcinoma: oncological outcomes from a multicenter study.腹腔镜与开放肾输尿管切除术治疗局限性和/或局部进展性上尿路尿路上皮癌:一项多中心研究的肿瘤学结果
BMC Surg. 2017 Jan 17;17(1):8. doi: 10.1186/s12893-016-0202-x.
10
Distal ureter and bladder cuff excision using the "Keyhole Technique" during Robotic Radical Nephroureterectomy.使用“钥匙孔技术”行机器人辅助根治性肾输尿管切除术时切除远端输尿管和膀胱袖套。
Int Braz J Urol. 2022 Sep-Oct;48(5):876-877. doi: 10.1590/S1677-5538.IBJU.2022.0147.

引用本文的文献

1
Robot-assisted radical nephroureterectomy using the KangDuo Surgical Robot-01 System versus the da Vinci System: a multicenter prospective randomized controlled trial.机器人辅助根治性肾输尿管切除术使用康多手术机器人-01 系统与达芬奇系统:一项多中心前瞻性随机对照试验。
Int Braz J Urol. 2024 Nov-Dec;50(6):727-736. doi: 10.1590/S1677-5538.IBJU.2024.0230.

本文引用的文献

1
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update.欧洲泌尿外科学会上尿路尿路上皮癌指南:2023 年更新版。
Eur Urol. 2023 Jul;84(1):49-64. doi: 10.1016/j.eururo.2023.03.013. Epub 2023 Mar 24.
2
Comparing Oncological and Perioperative Outcomes of Open versus Laparoscopic versus Robotic Radical Nephroureterectomy for the Treatment of Upper Tract Urothelial Carcinoma: A Multicenter, Multinational, Propensity Score-Matched Analysis.开放手术、腹腔镜手术与机器人辅助根治性肾输尿管切除术治疗上尿路尿路上皮癌的肿瘤学及围手术期结局比较:一项多中心、多国、倾向评分匹配分析
Cancers (Basel). 2023 Feb 23;15(5):1409. doi: 10.3390/cancers15051409.
3
Bladder Recurrence Following Upper Tract Surgery for Urothelial Carcinoma: A Contemporary Review of Risk Factors and Management Strategies.
上尿路尿路上皮癌手术后的膀胱复发:危险因素与管理策略的当代综述
Eur Urol Open Sci. 2023 Jan 28;49:60-66. doi: 10.1016/j.euros.2023.01.004. eCollection 2023 Mar.
4
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
5
Oncologic impact of delay between diagnosis and radical nephroureterectomy.诊断与根治性肾输尿管切除术之间延迟的肿瘤学影响。
Front Oncol. 2022 Dec 14;12:1025668. doi: 10.3389/fonc.2022.1025668. eCollection 2022.
6
Practice trends for perioperative intravesical chemotherapy in upper tract urothelial carcinoma: Low but increasing utilization during minimally invasive nephroureterectomy.上尿路尿路上皮癌围手术期膀胱内化疗的实践趋势:微创肾输尿管切除术期间的应用率虽低但呈上升趋势。
Urol Oncol. 2022 Oct;40(10):452.e17-452.e23. doi: 10.1016/j.urolonc.2022.06.006. Epub 2022 Aug 4.
7
Contemporary Trends of Systemic Neoadjuvant and Adjuvant Intravesical Chemotherapy in Patients With Upper Tract Urothelial Carcinomas Undergoing Minimally Invasive or Open Radical Nephroureterectomy: Analysis of US Claims on Perioperative Outcomes and Health Care Costs.微创或开放性根治性肾输尿管切除术治疗上尿路上皮癌患者的全身新辅助和辅助膀胱内化疗的当代趋势:美国围手术期结局和医疗保健成本索赔分析。
Clin Genitourin Cancer. 2022 Apr;20(2):198.e1-198.e9. doi: 10.1016/j.clgc.2021.11.016. Epub 2021 Dec 24.
8
Management of the Distal Ureter During Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Comprehensive Review of Literature.在上尿路尿路上皮癌行肾输尿管切除术时远端输尿管的处理:文献综述
Urol J. 2021 Nov 8;18(6):585-599. doi: 10.22037/uj.v18i.7024.
9
Evaluating the Oncological Outcomes of Pure Laparoscopic Radical Nephroureterectomy Performed for Upper-Tract Urothelial Carcinoma Patients: A Multicenter Cohort Study Adjusted by Propensity Score Matching.评估多中心队列研究调整后的倾向评分匹配法在上尿路尿路上皮癌患者中施行纯腹腔镜根治性肾输尿管切除术的肿瘤学结局。
Ann Surg Oncol. 2021 Jan;28(1):465-473. doi: 10.1245/s10434-020-09046-9. Epub 2020 Aug 25.
10
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update.欧洲泌尿外科学会上尿路尿路上皮癌指南:2020 年更新版。
Eur Urol. 2021 Jan;79(1):62-79. doi: 10.1016/j.eururo.2020.05.042. Epub 2020 Jun 24.